Treatment outcome of switching from ranibizumab to aflibercept in patients with central retinal vein occlusion

被引：0
|
作者：
Konidaris, V.
Gorgoli, K.
Burgula, S.
Deane, J.
Banerjee, S.
Empeslidis, T.
机构：
来源：
ACTA OPHTHALMOLOGICA | 2016年 / 94卷
关键词：
D O I：
10.1111/j.1755-3768.2016.0316
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] RESPONSE TO AFLIBERCEPT AS SECONDARY THERAPY IN PATIENTS WITH PERSISTENT RETINAL EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION INITIALLY TREATED WITH BEVACIZUMAB OR RANIBIZUMAB
    Eadie, James A.
    Ip, Michael S.
    Kulkarni, Amol D.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (12): : 2439 - 2443
  • [32] The Effect of Switching Ranibizumab to Aflibercept in Refractory Cases of Macular Edema Secondary to Ischemic Central Vein Occlusion
    Lehmann-Clarke, L.
    Dirani, A.
    Mantel, I.
    Ambresin, A.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2015, 232 (04) : 552 - 555
  • [33] COST-EFFECTIVENESS OF AFLIBERCEPT IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION IN TURKEY
    Tunalioglu, A.
    Ozdemir, O.
    Eldem, B.
    Unlu, N.
    Alp, M. N.
    Saatci, A. O.
    Ozmert, E.
    Deger, C.
    Asan, S.
    Sumer, F.
    Parali, E.
    Ozel, M. O.
    Erdal, E.
    Sar, C.
    VALUE IN HEALTH, 2015, 18 (03) : A181 - A182
  • [34] Efficacy-Based Aflibercept Treatment Regimen for Central Retinal Vein Occlusion
    Shimura, Masahiko
    Utsumi, Takuya
    Imazeki, Makoto
    Yasuda, Kanako
    Noma, Hidetaka
    OPHTHALMOLOGY RETINA, 2021, 5 (11): : 1177 - 1179
  • [35] Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study
    Rouvas, Alexander
    Petrou, Petros
    Vergados, Ioannis
    Pechtasides, Dimitrios
    Liarakos, Vasilios
    Mitsopoulou, Maria
    Ladas, Ioannis
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (12) : 1609 - 1616
  • [36] Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study
    Alexander Rouvas
    Petros Petrou
    Ioannis Vergados
    Dimitrios Pechtasides
    Vasilios Liarakos
    Maria Mitsopoulou
    Ioannis Ladas
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1609 - 1616
  • [37] Effects of Switching to Aflibercept in Treatment Resistant Macular Edema Secondary to Retinal Vein Occlusion
    Spooner, Kimberly
    Fraser-Bell, Samantha
    Hong, Thomas
    Chang, Andrew
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2020, 9 (01): : 48 - 53
  • [38] Efficacy of Dexamethasone Intravitreal Implant Compared with Intravitreal Ranibizumab in Patients with Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion
    Aydin, Erdinc
    Gurakar, Seda
    Egrilmez, Emine Deniz
    OPHTHALMOLOGICA, 2014, 232 : 87 - 87
  • [39] Ranibizumab and aflibercept intravitreal injection for treatment naive and refractory macular oedema in branch retinal vein occlusion
    Hogg, H. D. Jeffry
    Di Simplicio, Sandro
    Pearce, Mark S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (02) : 548 - 555
  • [40] Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study
    Becky Pennington
    Abualbishr Alshreef
    Laura Flight
    Andrew Metry
    Edith Poku
    Philip Hykin
    Sobha Sivaprasad
    A. Toby Prevost
    Joana C. Vasconcelos
    Caroline Murphy
    Joanna Kelly
    Yit Yang
    Andrew Lotery
    Michael Williams
    John Brazier
    PharmacoEconomics, 2021, 39 : 913 - 927
12345